Enliven Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Enliven Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2019 to Q3 2024.
  • Enliven Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $7.24M, a 100% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $7.24M +$3.63M +100% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $7.56M +$4.16M +122% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $4.09M +$686K +20.1% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $4.09M +$4.09M Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $3.61M Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $3.41M +$3.23M +1846% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $3.41M +$3.23M +1846% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $0 -$175K -100% Dec 31, 2022 10-K 2024-03-14
Q2 2022 $175K $0 0% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $175K -$133K -43.2% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $175K +$87K +98.9% Dec 31, 2021 10-K 2023-02-10
Q3 2021 $175K +$87K +98.9% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $175K -$149K -46% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $308K +$220K +250% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $88K -$2.14M -96.1% Dec 31, 2020 10-K 2022-03-15
Q3 2020 $88K Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $324K Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $88K Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $2.23M Dec 31, 2019 10-K 2021-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.